Trials / Completed
CompletedNCT00751361
Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial
Prospective, Randomized, Controlled Clinical Study Evaluating the Efficacy of Rheopheresis for Dry Age-Related Macular Degeneration Dry AMD Treatment With Rheopheresis Trial - ART
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Apheresis Research Institute · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Purpose is to evaluate Rheopheresis for the treatment of patients with high-risk dry age-related macular degeneration and no therapeutic alternative. Rheopheresis is a method of therapeutic apheresis using the methodology of double filtration plasmapheresis to treat microcirculatory disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rheopheresis / double filtration plasmapheresis | Rheopheresis is a specific method of therapeutic apheresis, using the methodology of double filtration plasmapheresis. |
Timeline
- Start date
- 1998-11-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2008-09-11
- Last updated
- 2008-09-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00751361. Inclusion in this directory is not an endorsement.